Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Swainsonine analogues in development at GlycoDesign as therapeutic agents

May 2, 2000

American Cyanamid describes new inhibitors of growth factor receptor PTKs useful in cancer Rx

May 2, 2000

Licensing opportunity from NIH: antibodies and immunotoxins for treating, diagnosing cancer

April 28, 2000

Licensing opportunity from NIH: MAb for the treatment, diagnosis of prostate cancer

April 28, 2000

Integrin antagonists disclosed by BioChem Pharma for inhibiting angiogenesis and tumor growth

April 28, 2000

AastromRepliCell System offers hope for CML patients

April 28, 2000

Lexicon Genetics issued patent on novel protein target for cancer treatments

April 27, 2000

Novel approach to stopping metastasis of aggressive prostate tumors

April 27, 2000

Large-scale production of Endostatin protein under way

April 27, 2000

Compounds and methods of treating proliferative diseases and hypercholesterolemia

April 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...